Adaptive Biotechnologies Corporation ( NASDAQ:ADPT – Get Free Report ) traded up 4.4% during mid-day trading on Thursday . The stock traded as high as $29.10 and last traded at $29.1230. Approximately 282,467 shares traded hands during mid-day trading, a decline of 88% from the average session volume of 2,287,464 shares. The stock had previously closed at $27.89.
Analysts Set New Price Targets Several research analysts recently commented on ADPT shares. Guggenheim raised their price objective on shares of Adaptive Biotechnologies from $22.00 to $25.00 and gave the stock a “buy” rating in a report on Thursday, July 30th. Weiss Ratings reissued a “sell (d-)” rating on shares of Adaptive Biotechnologies in a report on Friday, July 17th. BTIG Research increased their target price on Adaptive Biotechnologies from $25.00 to $34.00 and gave the stock a “buy” rating in a research report on Tuesday. Morgan Stanley raised their price target on Adaptive Biotechnologies from $20.00 to $22.00 and gave the stock an “equal weight” rating in a report on Thursday, July 30th. Finally, National Bank Financial set a $34.00 price target on Adaptive Biotechnologies in a research report on Tuesday. Five ...